[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 17, Issue 2 (Summer 2020) ::
Sci J Iran Blood Transfus Organ 2020, 17(2): 113-125 Back to browse issues page
Effect of curcumin and sorafenib on AKT gene expression in KG1 and U937 cell lines
R. Pazahr , M. Mohammadikian , E. Ali Asgari , S. Mohammadi , Sh. Rostami , B. Chahardolii , D. Babakhani , M. Nikbakht
Abstract:   (2200 Views)
Abstract
Background and Objectives
Acute myeloid leukemia is a heterozygous hematologic malignancy that is manifested by the     accumulation of hematopoietics stem cells in peripheral blood and bone marrow. Anticancer effects and  cryotoxic activity of curcumin have been proven frequently in many cancers. Sorafenib is known as an inhibitor of angiogenesis which prevent cells’ survival. In the present study, the effects of curcumin and sorafenib and their combination were evaluated on AML cells.
 
Materials and Methods
In this experimental study, U937 and KG-1 cells were treated with different concentration of curcumin and sorafenib and their combination.  MTT assay was applied to assess the viability of cells.  Percentage of apoptotic cells was evaluated by annexin PI staining. Also Real Time PCR was performed to investigte the level of  AKT mRNA expression.
 
Results
Our data showed that the percentage of apoptotic cells significantly increased in response to treatment with  curcumin (40µM in KG-1 and U937 cell lines), sorafenib (5 µM and 7 µM in U937 and KG-1, respectively) and their combination. Moreover, the mRNA level of AKT gene was downregulated in KG-1 and U937 cells.
 
Conclusions 
Our results suggest that combination of curcumin and sorafenib could lead to promote apoptosis. Furthurermore, downregulation of AKT gene shows that these agents can be considered as effective agents on AML cells. 
 
Keywords: Key words: Acute Myeloid Leukemia, Curcumin, Sorafenib
Full-Text [PDF 843 kb]   (1093 Downloads) |   |   Full-Text (HTML)  (1917 Views)  
Type of Study: Research | Subject: Hematology and Oncology
Published: 2020/06/30
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pazahr R, Mohammadikian M, Ali Asgari E, Mohammadi S, Rostami S, Chahardolii B, et al . Effect of curcumin and sorafenib on AKT gene expression in KG1 and U937 cell lines. Sci J Iran Blood Transfus Organ 2020; 17 (2) :113-125
URL: http://bloodjournal.ir/article-1-1297-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 17, Issue 2 (Summer 2020) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4645